Enacted on October 13, 2009.
Title changed and amended on October 18, 2013.
Amended on October 30, 2015

Article 1 (Purpose)

The purpose of these guidelines is to review articles submitted to JKSHP according to Article 5 of the Articles of Association of The Korean Society of Health-system Pharmacists and Article 19 of the JKSHP Publication Guidelines. (Amended on 13.10.18)

Article 2 (Article submission)

Articles shall be reviewed and accepted according to these guidelines. (Amended on 13.10.18)

Article 3 (Selection of reviewers and request for review) (Amended on October 30, 2015)

• 1. The Editorial Board confirms the checklists submitted with the articles, appoints 2 reviewers and requests reviews for the articles that may be reviewed. (Amended on October 30, 2015)
• 2. Reviewers are selected by the Editor-in-Chief among experts with considerable research achievements in the field of pharmacy based on opinions collected from editors. Editors may also be selected as reviewers. (Amended on October 30, 2015)
• 3. (Deleted on October 30, 2015)
• 4. (Deleted on October 30, 2015)

Article 3-1 (Review procedures) (established on October 30, 2015)

• 1. Reviewers are to review the articles without any possibility of identifying the name or affiliation the contributors.
• 2. Articles are strictly reviewed based on the review criteria.
• 3. Names of reviewers and the review process are not disclosed.
• 4. Reviewers shall review the designated manuscripts within 10 days of being appointed as reviewers.

Article 3-2 (Review criteria)

Articles are reviewed for originality of research topic, suitability of research methods, validity in development of logic, and fulfillment of requirements and structure. (established on October 30, 2015)

Article 4 (Review results)

Review results are classified into 4 levels: <acceptable for publication>, <acceptable for publication following revisions>, <reconsideration possible after revisions>, <rejected>. (Amended on October 30, 2015)

• 1. Articles that are <acceptable for publication> are accepted without revisions.
• 2. Articles that are <acceptable for publication following revisions> are sent to the authors, who revise the matters pointed out by the reviewers, after which the reviewers or editors check and accept them.
• 3. Articles with <reconsideration possible after revisions> are sent to the authors, who revise the matters pointed out by the reviewers, after which the reviewers who determined the articles as <reconsideration possible after revisions> review the articles again to decide on whether to accept or not.
• 4. Criteria for <rejected> are when the content of the article is relevant to one of the following:
  • A. When the research topic lacks pharmacological significance
  • B. When the article plagiarized parts of research by others already published
  • C. When the article lacks reliability or validity of results
  • D. When the article has at least 30% of items evaluated as 'Very Poor' in review results
  • E. When the article is considered impossible to revise

Article 5 (Determination of results)

After collecting the revised articles, the Editor-in-Chief calls an editorial meeting and examines the contents of review. (Amended on October 18, 2013)

• 1. Articles that are determined as <acceptable for publication> by two reviewers are sent to the contributors for final proofreading. (Amended on October 30, 2015)
• 2. Articles that are determined as <acceptable for publication following revisions> and <reconsideration possible after revisions> are sent to the contributors for revisions with the evaluation of the reviewers attached.
• 3. Articles that are determined as <rejected> by one or more reviewer are not admitted for publication. (Amended on October 30, 2015)
• 4. If articles are regarded inappropriate for JKSHP submission and preparation guidelines by the Editorial Board regardless of review results, they are not accepted. (Amended on October 30, 2015)
• 5. If contributors fail to submit the revised manuscripts by the indicated deadline, the publication will be postponed to the next issue or will be considered as being withdrawn.

Article 6 (Notification of results)

The Editor-in-Chief collects the revised articles and confirms with the relevant reviewers regarding the fulfillment of revisions for articles determined as <acceptable for publication following revisions > and <reconsideration possible after revisions>, and then finally decides on publication of the articles. (Amended on October 18, 2013)

• 1. The Editor-in-Chief notifies the contributors by dividing the final review results of revised articles into <acceptable for publication> and <rejected>.
• 2. From this point, contributors may receive a certificate of acceptance and publication of article upon request.
• 3. The details of review are not disclosed to those other than the authors.

• Supplementary rules (October 13, 2009)
• ① (Enforcement date) The submission rules shall come into effect from the date of resolution by the Board of Directors.
• ② (Transitional provision) Works executed before the effectuation of the supplementary rules may be regarded to have been executed in accordance with the rules.
• Supplementary rules (October 18, 2013)
• ① (Enforcement date) The submission rules shall come into effect from the date of resolution by the Board of Directors.
• ② (Transitional provision) Works executed before the effectuation of the supplementary rules may be regarded to have been executed in accordance with the rules.
• Supplementary rules (October 30, 2015)
• ① (Enforcement date) The submission rules shall come into effect from the date of resolution by the Board of Directors. However, Article 3, Article 5, revised provisions shall come into force from March 2016.